BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 27398060)

  • 1. Human antibody response to dengue virus: implications for dengue vaccine design.
    Moi ML; Takasaki T; Kurane I
    Trop Med Health; 2016; 44():1. PubMed ID: 27398060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dengue fever: from disease to vaccination].
    Teyssou R
    Med Trop (Mars); 2009 Aug; 69(4):333-4. PubMed ID: 19725380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding dengue pathogenesis: implications for vaccine design.
    Stephenson JR
    Bull World Health Organ; 2005 Apr; 83(4):308-14. PubMed ID: 15868023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dengue virus vaccine development.
    Yauch LE; Shresta S
    Adv Virus Res; 2014; 88():315-72. PubMed ID: 24373316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanistic role of antibodies to dengue virus in protection and disease pathogenesis.
    Gan ES; Ting DH; Chan KR
    Expert Rev Anti Infect Ther; 2017 Feb; 15(2):111-119. PubMed ID: 27796143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines licensed and in clinical trials for the prevention of dengue.
    Torresi J; Ebert G; Pellegrini M
    Hum Vaccin Immunother; 2017 May; 13(5):1059-1072. PubMed ID: 28281864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dengue Vaccines: Ongoing Challenges and Current Status in the Advancement of Different Candidates.
    Hassan M; Hassan A; Farooq M; Afzal S; Khan MA; Amin I; Shahid M; Idrees M; Shahid AA
    Crit Rev Eukaryot Gene Expr; 2021; 31(5):7-19. PubMed ID: 34591385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dengue determinants: Necessities and challenges for universal dengue vaccine development.
    Hussain Z; Rani S; Ma F; Li W; Shen W; Gao T; Wang J; Pei R
    Rev Med Virol; 2023 Mar; 33(2):e2425. PubMed ID: 36683235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammalian animal models for dengue virus infection: a recent overview.
    Kayesh MEH; Tsukiyama-Kohara K
    Arch Virol; 2022 Jan; 167(1):31-44. PubMed ID: 34761286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outlook for a dengue vaccine.
    Norrby R
    Clin Microbiol Infect; 2014 May; 20 Suppl 5():92-4. PubMed ID: 24438016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective cohort studies of dengue viral transmission and severity of disease.
    Endy TP; Yoon IK; Mammen MP
    Curr Top Microbiol Immunol; 2010; 338():1-13. PubMed ID: 19802574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dengue virus: epidemiology, biology, and disease aetiology.
    Roy SK; Bhattacharjee S
    Can J Microbiol; 2021 Oct; 67(10):687-702. PubMed ID: 34171205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dengue vaccine development: strategies and challenges.
    Ramakrishnan L; Pillai MR; Nair RR
    Viral Immunol; 2015 Mar; 28(2):76-84. PubMed ID: 25494228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmunity in dengue pathogenesis.
    Wan SW; Lin CF; Yeh TM; Liu CC; Liu HS; Wang S; Ling P; Anderson R; Lei HY; Lin YS
    J Formos Med Assoc; 2013 Jan; 112(1):3-11. PubMed ID: 23332423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine.
    Shukla R; Ramasamy V; Shanmugam RK; Ahuja R; Khanna N
    Front Cell Infect Microbiol; 2020; 10():572681. PubMed ID: 33194810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of cell-surface displayed synthetic consensus dengue EDIII cells as a potent oral vaccine candidate.
    Bal J; Jung HY; Nguyen LN; Park J; Jang YS; Kim DH
    Microb Cell Fact; 2018 Sep; 17(1):146. PubMed ID: 30217208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Molecular Specificity of the Human Antibody Response to Dengue Virus Infections.
    Gallichotte EN; Baric RS; de Silva AM
    Adv Exp Med Biol; 2018; 1062():63-76. PubMed ID: 29845525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targets and strategies for vaccine development against dengue viruses.
    Wang WH; Urbina AN; Lin CY; Yang ZS; Assavalapsakul W; Thitithanyanont A; Lu PL; Chen YH; Wang SF
    Biomed Pharmacother; 2021 Dec; 144():112304. PubMed ID: 34634560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-Dependent Dengue Virus Entry Modulates Cell Intrinsic Responses for Enhanced Infection.
    Chan CYY; Low JZH; Gan ES; Ong EZ; Zhang SL; Tan HC; Chai X; Ghosh S; Ooi EE; Chan KR
    mSphere; 2019 Sep; 4(5):. PubMed ID: 31533998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress in dengue vaccine development.
    Wei J; Chen H; An J
    Virol Sin; 2014 Dec; 29(6):353-63. PubMed ID: 25547681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.